Employees
~500
Stage
Preclinical
Modalities
Small interfering RNA (siRNA)RNA interference (RNAi)Small molecule

Buck Institute for Research on Aging General Information

Research institute focused on aging and age-related diseases, with partnerships for drug development. Notable collaboration with Insilico Medicine and Juvenescence to form Napa Therapeutics for developing drugs against aging-related targets.

Contact Information

Website
Primary Industry
Academic
Corporate Office
Novato, California
United States

Drug Pipeline

No pipeline data available

For full access to Buck Institute for Research on Aging's pipeline data

Book a demo

Key Partnerships

Insilico Medicine, Juvenescence, Napa Therapeutics

Need more data on over 80,000 life science companies, including over 1200 biotechs?

Book a demo

Buck Institute for Research on Aging Funding

Deal TypeDateAmountStatusStage
Early Stage VC (Series A)04-Jun-2020$38MCompletedPhase 1
Seed Round12-Feb-2019$8.5MCompletedStartup

Interested in comprehensive profile data?

We'll help you find what you need

Learn more
To view Buck Institute for Research on Aging's complete valuation and funding history, request access »